TIDES Europe: Oligonucleotide and Peptide Therapeutics is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Andreas Wagner
Head of Liposome Technology at Polymun Scientific GmbH

Profile

Dr Andreas Wagner is currently the Head of Liposome Technology at Polymun Scientific GmbH in Klosterneuburg, Austria. He has significant expertise in development and optimization of liposomal drug products. Over the last 15 years, his group guided approx. 15 different liposomal drug products into clinical trials. He studied Biotechnology in Vienna, Austria and earned his Master and Ph.D. degrees in the field of liposomology at the Institute of Applied Microbiology supervised by Prof. Hermann Katinger. Dr Andreas Wagner is listed as inventor on several patents, like the liposome technology and some product patents of liposomal formulations and he has published several peer reviewed articles dealing with liposomes, the technology, products thereof and their application in preclinical and clinical studies.

Andreas Wagner's Network

Agenda Sessions

  • Guiding RNA Formulations from Laboratory into Clinical Trials. Lessons Learned from Development and Optimization of Liposomal Formulations

    , 12:00